News
Source: MHRA 24.8.26 The NGPod handheld device and NGPod sensor, used to test pH to aid the placement of nasogastric tubes, is being withdrawn from the UK market. The manufacturer...
National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators:
Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA) Source: MHRA 17.8.26 ResMed has issued a Field Safety Notice regarding Astral 100 and 150 ventilators and associated...
Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37
Source: MHRA 20.8.26 Zentiva UK Pharma Limited are recalling one batch of Fingolimod Zentiva 0.5 mg Capsules (BN 4L01372H) as a precautionary measure due to a potential risk of contamination...
All rectal catheters (gas and colic relievers):
Do not use in infants, including for the treatment of colic, gas-related discomfort or constipation (DSI/2026/008) Source: MHRA 18.8.26 Do not use rectal catheters in infants, including for colic, gas-related...
Supporting Dispensing Practices with Dispex AI
By Dispex Spotlight: SOPs on Demand with Dispex AI A Dispex member contacted the office following their DSQS dispensary review. They required a SOP for dispensing prescriptions not generated by...
How to Access Dispex’s Guide to Understanding your PCSE Drug Statement
Exclusive Members’ Resource Keeping a watchful eye on your PCSE drug statements and prescription charges has always been an important aspect of best practice. However, in light of the present...
Dispex Training Options
Dispex is the UK’s leading provider of dispensary training and profitability reviews, delivered through flexible remote and on-site support. You may be eligible for PCN Leadership & Management Funding – Click...
Generics costing more than the Drug Tariff
Each month over 80 commonly dispensed generics, as priced in the Drug Tariff or DM+D, are priced at a lower price than the purchase price. When you take the clawback...
Another 8 products added to category H from September
Eight products will be moving from Drug Tariff Part VIIIA Category C to Category H, effective from September 2026. Members can click here to see the list in full.
Devices supplied without valid UKCA/CE conformity markings or certification: remove from use and place in quarantine (DSI/2026/007)
Source: MHRA 10.08.2026 The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK...
Statement about Staladex from the manufacturer
By Dr Philip Koopowitz As of 1st August, the list price of Staladex (Leuprorelin Acetate 11.25mg) has lowered the list price to £75 per dose (from £206). Aspire Pharma have...
Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update to DSI/2023/005)
Source: MHRA 06.08.2026 The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs. This DSI replaces advice in DSI/2023/005 Summary The...
